Clinical Trial Update: Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial evaluating autologous bone marrow-derived mononuclear cells for diabetic patients with critical limb ischemia; the study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot
• Peripheral Vascular Disease

Drugs mentioned

• Autologous bone marrow-derived mononuclear cells (bone marrow-derived mononuclear cells)

Snippet

Sponsor: Andalusian Network for Design and Translation of Advanced Therapies | Conditions: Peripheral Vascular Diseases, Diabetic Foot | Phase 1, Phase 2 | Status: COMPLETED